PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $398,901 | -23.0% | 13,002 | +0.5% | 0.00% | 0.0% |
| Q2 2023 | $518,185 | -17.6% | 12,932 | -16.1% | 0.00% | 0.0% |
| Q1 2023 | $628,964 | +5.7% | 15,412 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $595,057 | -27.5% | 15,412 | -0.2% | 0.00% | -50.0% |
| Q3 2022 | $821,000 | -8.8% | 15,442 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $900,000 | -32.4% | 15,442 | -11.5% | 0.00% | -33.3% |
| Q1 2022 | $1,332,000 | +26.9% | 17,452 | 0.0% | 0.00% | +50.0% |
| Q4 2021 | $1,050,000 | +3.4% | 17,452 | -3.7% | 0.00% | 0.0% |
| Q3 2021 | $1,015,000 | -7.7% | 18,121 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,100,000 | -52.6% | 18,121 | -45.2% | 0.00% | -60.0% |
| Q1 2021 | $2,319,000 | +12.7% | 33,093 | -3.7% | 0.01% | +25.0% |
| Q4 2020 | $2,057,000 | -6.6% | 34,373 | -6.1% | 0.00% | -20.0% |
| Q3 2020 | $2,202,000 | +95.0% | 36,623 | +70.2% | 0.01% | +66.7% |
| Q2 2020 | $1,129,000 | +56.4% | 21,521 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $722,000 | -25.9% | 21,521 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $975,000 | +14.6% | 21,521 | -3.7% | 0.00% | 0.0% |
| Q3 2019 | $851,000 | -12.4% | 22,351 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $972,000 | -4.9% | 22,351 | -16.7% | 0.00% | 0.0% |
| Q1 2019 | $1,022,000 | -0.5% | 26,844 | +12.4% | 0.00% | 0.0% |
| Q4 2018 | $1,027,000 | -17.2% | 23,881 | -5.4% | 0.00% | 0.0% |
| Q3 2018 | $1,241,000 | +53.4% | 25,248 | 0.0% | 0.00% | +50.0% |
| Q2 2018 | $809,000 | +16.1% | 25,248 | +12.8% | 0.00% | 0.0% |
| Q1 2018 | $697,000 | -31.8% | 22,388 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $1,022,000 | +11.9% | 22,388 | -7.9% | 0.00% | +50.0% |
| Q3 2017 | $913,000 | -21.2% | 24,308 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $1,159,000 | +4.6% | 24,308 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $1,108,000 | +28.1% | 24,308 | -9.2% | 0.00% | 0.0% |
| Q4 2016 | $865,000 | -5.6% | 26,778 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $916,000 | -1.5% | 26,778 | -2.9% | 0.00% | 0.0% |
| Q2 2016 | $930,000 | -30.4% | 27,578 | +9.3% | 0.00% | -40.0% |
| Q1 2016 | $1,337,000 | -34.7% | 25,230 | -5.3% | 0.01% | -37.5% |
| Q4 2015 | $2,046,000 | +86.8% | 26,650 | 0.0% | 0.01% | +100.0% |
| Q3 2015 | $1,095,000 | -41.9% | 26,650 | 0.0% | 0.00% | -42.9% |
| Q2 2015 | $1,885,000 | -22.9% | 26,650 | -3.1% | 0.01% | -12.5% |
| Q1 2015 | $2,444,000 | -5.5% | 27,506 | -5.6% | 0.01% | 0.0% |
| Q4 2014 | $2,585,000 | -10.5% | 29,152 | -2.2% | 0.01% | -11.1% |
| Q3 2014 | $2,889,000 | +2.6% | 29,803 | -2.7% | 0.01% | 0.0% |
| Q2 2014 | $2,815,000 | +93.5% | 30,643 | +47.4% | 0.01% | +80.0% |
| Q1 2014 | $1,455,000 | +21.8% | 20,786 | 0.0% | 0.01% | +25.0% |
| Q4 2013 | $1,195,000 | +15.3% | 20,786 | -3.5% | 0.00% | +33.3% |
| Q3 2013 | $1,036,000 | +65.8% | 21,551 | 0.0% | 0.00% | +50.0% |
| Q2 2013 | $625,000 | – | 21,551 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 563,415 | $21,753,453 | 4.80% |
| Gagnon Advisors, LLC | 180,331 | $6,962,579 | 4.70% |
| Spyglass Capital Management LLC | 868,686 | $33,539,966 | 2.69% |
| Tamarack Advisers, LP | 100,000 | $3,861,000 | 1.99% |
| ARMISTICE CAPITAL, LLC | 1,892,000 | $73,050,120 | 1.27% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 276,590 | $10,679,140 | 0.99% |
| RICE HALL JAMES & ASSOCIATES, LLC | 437,285 | $16,883,574 | 0.97% |
| Rock Springs Capital Management LP | 1,032,600 | $39,868,686 | 0.96% |
| OUTFITTER FINANCIAL LLC | 25,860 | $998,455 | 0.91% |
| Stephens Investment Management Group LLC | 1,168,469 | $45,535,237 | 0.82% |